Objective To determine whether a different renal histopathology is associated with the characteristic IgG subclass distribution, and whether a distinct IgG subclass distribution is involved in a unique immunopathological expression, we compared the distributions of glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis (DPLN), membranous LN (MLN), and idiopathic membranous nephropathy (MN).
Introduction
HumanIgG molecules are classified into four different IgG subclasses according to the immunologically distinct constant region of the heavy chain. Accordingly, different IgG subclasses have distinct physicochemical and biological properties (1) .
Apparently, the IgG class of antibodies is the most important Ig isotype in immunopathogenesis for both lupus nephritis (LN) and idiopathic membranousnephropathy (MN), because they unequivocally have glomerular IgG deposits (2) .
Using an animal model, experimental studies on the pathogenic significance of murine IgG3 in autoimmune MRL/MpJIprllpr mice (3) suggest that a particular IgG subclass maybe operative in the development of an immune-complex (IC) type of glomerulonephritis (ICGN) in man. Several investigators determined by immunofluorescence microscopy (IF) the deposition of IgG subclasses in patients with ICGN, such as LN, MNand membranoproliferative glomerulonephritis (4) (5) (6) (7) (8) (9) . However, the glomerular IgG subclass distribution in membranous lupus nephritis (MLN), which is characterized by diffuse thickening of glomerular capillary walls, is still controversial (5, 8) . In addition, it is uncertain whether an essential IgG subclass exists in membranous glomerulopathy, such as MNand MLN.Furthermore, the significance of serum IgG subclass levels in MN remains unclear. In the present study, to determine whether a different renal histopathology is associated with the characteristic IgG subclass distribution, and whether a distinct IgG subclass distribution is involved in the unique immunopathological expression, we compared the distributions of glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis (DPLN), which is the most severe type of proliferative LN, MLN,and MN.Our results indicate that the IgG subclass distribution is not associated with the different histopathological expressions of DPLNand MLN,and suggest that IgG4 is closely related to MN,which is not applicable to another form of membranous glomerulopathy, MLN.Wewill also discuss the role of IgG4 in the development of MN.
Patients and Methods

Patien ts
Renal biopsy specimens were obtained from 17 patients with systemic lupus erthematosus (SLE) and 16 patients with MN who were diagnosed based on the clinical and renal biopsy findings in our department. All the patients with SLEfulfilled the 1982 revised criteria of the American RheumatismAssociation (10) for establishing a diagnosis of SLE. Renal biopsy specimens were divided and processed for light, immunofluorescence and electron microscopies. For IF, renal tissues were snap frozen in liquid nitrogen and cut into 4 Jim sections. The glomerular deposits of IgG, IgM, IgA, Clq and C3 in the biopsy specimens were examined by routine IF and significant glomerular IgG deposits in LNand MNwere substantiated. The histological classification of LN was performed according to the World Health Organization morphologic classification (2), by which seven patients with DPLN(class IV) and 10 patients with MLN(class V) were enrolled in the present study. In the DPLNgroup, five patients were classified as class IVA, one patient as class IVB, and one patient as class IVD. In the MLNgroup, three patients were classified as class VA, and seven patients as class VB.The histological stage was examined in 15 of 16 patients with MNwhowere then classified into four stages according to the electron microscopic findings (2) . Ten patients were classified as stage II, one patient as stage II-III, and four patients as stage III. All of the patients with SLE presented active renal manifestations with hypocomplementemia. The patients with MNhad no systemic diseases that are possibly related to the development of membranous nephropathy.
Serum samples Serumsamples were obtained from the patients with LNor MN,near the time of renal biopsy. Fourteen normal human serum (NHS) samples were obtained from healthy volunteers. Blood samples were allowed to clot at 37°C for 30 minutes to avoid cryoprecipitation, then the separated sera were frozen at -20°C until use.
Polyclonal an tibodies FITC-conjugated goat anti-human IgG, IgM, IgA, Clq and C3 specific antibodies, and the purified IgG fraction of goat anti-human IgM specific antibodies were purchased from Cappel Laboratories (West Chester, PA, USA). The alkalinephosphatase (AP)-conjugated mouse anti-human IgG specific antibodies were purchased from Jackson Immunoresearch Laboratories Inc. (West Grove, PA, USA).
Monoclonal antibodies (mAbs)
The FITC-conjugated mouse anti-human IgG subclass specific mAbsused were as follows: clone Nos. HP-6069 (ZYMED 
Glomerular IgG subclasses
Glomerular IgG subclass deposition was examined by direct IF using FITC-conjugated mouse anti-human IgG subclass specific mAbs. The fluorescence intensity of glomerular staining was graded as follows: negative, 0; very weak, 0.5; weak, 1 ; moderate, 2; and strong, 3, and scored for each biopsy specimen. The results are expressed as the frequency of positive biopsies (percentage) and the intensity of fluorescence (mean score) for each IgG subclass.
ELISA of IgG subclasses and IgM
IgG subclass levels in sera were quantitated by IgG subclass specific sandwich ELISA as described by Hamilton (13) with minor modifications, according to an ELISA procedure published previously (14) . Briefly, microtiter plates (Nunc, Roskilde, Denmark) were coated with one of the purified IgG fractions of humanIgG subclass specific mouse mAbsat 5 jLLg/ ml for HP6069, HP6002 and HP6025, and at 2.5 |ug/ml for HP6047 as capture antibodies. Then, appropriately diluted serumsampleswere addedto microtiter wells. Theassays were developed with AP-conjugated mouse polyclonal anti-human IgG specific antibodies as detection antibodies. The reactivities and specificities of the ELISAof IgG subclasses were substantiated by constructing dose-response curves for serial dilutions (two fold) of four different IgG subclasses of the human myeloma protein, ranging from 1,000 ng/ml to 2 ng/ml. When Sta tis tical analysis Statistical analysis was performed with the Mann-Whitney U test. Probability values greater than 5%were considered insignificant.
Results
Patien t characteristics Clinical parameters of the DPLN(7 female), MLN(10 female) and MN(ll male and 5 female) patients are shown in DPLN, MLN) . A significant level of urine protein and decreased levels of mean serum total protein and albumin were observed in these three groups of patients. There were no significant differences in levels of urine protein, serum total protein, serum albumin and serum creatinine in the three groups of patients.
Glomerular IgG subclass distribution in DPLN, MLNand MN patien ts Glomerular IgG subclass distributions in the DPLN, MLN and MNgroups are shown in Fig. 1 . In the DPLNgroup, there was no significant difference in the frequency of each IgG subclass deposition. Regarding the mean score of each IgG subclass deposition, that of IgG4 deposition (0.36±0.38, mean±SD) was significantly lower than those of IgG2 (1.29±0.70) and IgG3 (1.00+0.58) in the DPLN group (Fig. 1A) . In the MLN group, IgG2 deposition frequency was significantly high (100%) compared with IgG3 (60%) and IgG4 (60%), and the mean score of IgG4 deposition (0.50±0.62) was lower than those ofIgGl (0.85±0.34) and IgG2 (1.30+0.48) (Fig. IB) . Overall, IgGl, IgG2 and IgG3, and, to a lesser degree, IgG4, were similarly present in glomerular deposits in both DPLN and MLNgroups. In the MNgroup, IgG4 and IgGl were the dominant glomerular IgG subclasses, because IgG4 was present in 100%of the biopsies and IgGl in 88%. On the other hand, both IgG2 and IgG3 were present in 25% of the biopsies studied. Regarding the meanscore of each IgG subclass, a strikingly high mean score of IgG4 deposition (1.94±0.85) and a significant, but weak IgGl deposition (0.72±0.36) were noted. In contrast, the meanscores of IgG2 and IgG3 depositions were very low (0. 16±0.30) (Fig. 1C) with those in NHS, their differences were statistically insignificant. Regarding the mean %IgGsubclasses, they were not significantly different from that in NHS, except for the increased %IgGl in the MLNgroup. Notably, there were no significant differences in the levels of serum IgG subclasses between the DPLNand MLNgroups. In MNgroup, the mean serum concentrations of IgG1, IgG2 and IgG3 were significantly lower than those in the NHS. In contrast, the serum IgG4 concentration was elevated, although the elevation wasstatistically insignificant. Whenthe mean %IgGsubclasses were compared with that in NHS, the %IgGl, %IgG2, and %IgG3 were almost comparable. However, the %IgG4 significantly increased in the MNgroup. Whenthe serum levels of total IgG in the three groups of patients were compared with that in NHS, a significant difference was observed in only the MNgroup.
Serum IgM and IgE levels in DPLN, MLNand MNpatients
The levels of serum IgM and IgE in the DPLN, MLNand MNgroups are shown in Table 3 . In the DPLN, MLNand MN groups, serum IgM levels were not significantly different from that in NHS. Although serum IgE levels were elevated in the three groups of patients, a significantly higher value was observed in only the MLNgroup (p<0.05, vs NHS).
Discussion
By comparing the glomerular IgG subclass distribution in the three groups of patients with DPLN, MLN,or MN,we have shown that IgG4 is the distinctive glomerular IgG subclass in the MNgroup. In contrast, predominant deposition of IgG4 was found in neither the MLNnor DPLNgroup, but rather the staining intensity of IgG4 deposition was less than those of other IgG subclasses. Furthermore, we have shown that serum IgG4 levels were selectively elevated in patients with MN.Thus, the predominant deposition of IgG4 along the glomerular capillary wall and the elevated serum IgG4 levels in patients with MNsupport the distinctive significance of IgG4 in the immunopathogenesis of MN.
In the present patients with MN,the data on the glomerular IgG subclass distribution obtained by IF are almost in agreement with previous reports (6, 7), but at variance in the positive frequency or staining intensity of each IgG subclass. A significant but weak deposition of IgGl in association with remarkable IgG4 deposition was noted in the MNgroup. Regarding the glomerular IgG subclasses in LN, although diverse reports were published, comparative study of the glomerular IgG subclass deposition between DPLNand MLNwas not performed, except for the study by Roberts et al (5) . They showed the predominant deposition of IgGl and IgG3 in DPLN patients, but that of IgG4 in MLNpatients. Moreover, they suggested that the distinct IgG subclass distribution might be responsible for the unique histopathology via different complement activating capabilities of glomerular IgG subclasses. However, our data contradict this hypothesis, because IgGl, IgG2 and IgG3 were significantly distributed in both the DPLN and MLNgroups. Accordingly, the distinct histopathologic expressions of DPLNand MLNcould not be explained by the glomerular IgG subclass distribution. In this regard, Haas noted that all the IgG subclasses were present in patients with MLN, but the staining intensity of IgG3 exceeded that of IgG4 (8) . Possibly, such different results maybe due to either the difference in reagents used, such as FITC-conjugated antibodies applied in IF, or difference in populations of patients. The present results of the comparative study of the glomerular IgG subclass deposition between MLNand MNindicate that IgG4 is the predominant glomerular IgG subclass in MN,but not in another form of membranous glomerulopathy, MLN.This finding agrees with that of Haas (8) . The most notable observation in the present study was the significant increase in the %IgG4associated with a slightly elevated serum IgG4 concentration in patients with MN,although the serum concentrations of the other three IgG subclasses decreased. This indicates that IgG4 production but not that of other IgG subclasses may be significantly enhanced, and that would be related to glomerular deposition of IgG4, in combination with still undetermined nephritogenic antigen(s) in MN. Thus, it can be proposed that IgG4 is related to the immunopathogenesisof MN,even if the extent of its serum concentration elevation is relatively low. Although it seemed that the IgG subclass levels increased in the sera from DPLN and MLNpatients, the mean concentration of each IgG subclass and the %IgGsubclass were not significantly different from those in NHS, except for the increased %IgGl in MLN. In addition, the serum IgE levels were significantly increased only in patients with MLN.These results may reflect in part the overall activation of B cells in SLE. However, the significance of the levels of serum IgG subclasses in LNis still unclear.
One of the factors that may influence the serum IgG subclass levels in patients with glomerular disease whodevelop either nephrotic syndromeor a moderatedegree of proteinuria, is urinary excretion of IgG subclasses. In addition, the depression of the serum IgG levels in patients with nephrotic syndrome due to a primary glomerulopathy, such as minimal change nephrotic syndrome (MCNS) and MNmay be considered (15) (16) (17) . However, since IgG subclasses appear in the urine in proportions similar to their relative concentrations in the serum (15) , the possibility of selective urinary loss of particular IgG subclasses can be excluded. Furthermore, the report that the synthesis of IgG by pokeweed mitogen-stimulated peripheral blood lymphocytes is diminished in MNand MCNSin vitro (16, 17) supports the idea that the variable levels of serum IgG subclasses in patients with LNor MNare determined by the difference in the production rate of each IgG subclass. In this context, the increase in the %IgG4in association with a slightly elevated serum IgG4 concentration, while the total serum IgG level is decreased in patients with MN,is significant. In the present study, we have shown that levels of serum IgG4 are elevated in patients with MN.Other investigators reported conflicting results, in which they described that neither serum IgG4 concentration nor %IgG4is increased (7, 9) . This discrepancy maybe partly ascribed to either the ELISAmethodology employed, or the difference in patients' profile, such as the clinical course, because MNis subject to fluctuations in disease activity.
MNis an ICGNinduced by either circulating ICs or in situ IC formation or both pathogeneses (18) . Howis IgG4 involved in the subepithelial immune-deposit formation in MN?Several hypothetical roles of IgG4 could be discussed. First, the size of IgG4-containing IC may be small, which makes it easy to be localized along the capillary wall, since it has been reported that IgG4 antibodies form small, nonprecipitating ICs (19) . Second, the affinity of IgG4 may be low in MN, because ICs tend to be smaller and localize in subepithelial spaces when low-affinity antibodies are produced (18) . A previous study indicated that the level of IgG4 CIC composed of low-avidity antibodies was increased in 10 of 35 patients with MN (20) . Third, the charge of IgG4 or IgG4-containing ICs may be critical, because the capillary wall would be more accessible to cationically charged molecules via charge interactions (1 8) . In this respect, as the chargeof IgG4is moreanionic than those of other IgG subclasses (13) , the charge of the corresponding antigen(s) of IgG4 would be cationic in MN, which facilitates its localization along the glomerular basement membrane, leading to subepithelial immune-deposit formation by complexing with circulating IgG4 in situ. Alternatively, it is of special interest to note a recent proposal of Zack et al regarding the unique characteristic of IgG4, that is, its constant region possesses IgG Fc-binding reactivities (21) . If serum IgG4 in MNrepresents such immunochemical property, this maybe responsible for a novel mechanismof IC formation in situ. This issue is under investigation in our laboratory. Thus, although the nature of IgG4 needs to be determined in the future, the IgG4 molecule in MNmay have unique immunological properties that are related to the subepithelial immune-deposit formation. Production of IgGl and IgG3, or IgG2 antibodies is stimulated by protein antigens or carbohydrate antigens, respectively (1, 13) . Regarding IgG4, it has been reported that prolonged antigenic stimulation results in IgG4 antibody production (22) . Accordingly, it is very important to determine antigenic stimuli that induce IgG4 production in MN. At present, the specificities of IgG4 and the mechanisms of IgG4 production in MN remain unclear. In recent years, human IgG subclass production and switch mechanismshave been elucidated in part on the basis of the role ofTh cell-derived cytokines (23) (24) (25) . The increase in %IgG4 in MNsera may indicate the involvement of Th2 cytokines, such as IL-4, although the increase is not accompanied by significant elevation of IgE levels. Interestingly, Jeannin et al recently reported the role of IL-10 in the differential production of IgG4 and IgE in vitro (26) . Therefore, certain cytokines mayparticipate in the selective production of IgG4in MN.Further studies on the role of IgG4 in the pathogenesis of MNmayprovide important information that may lead to the development of therapeutic approaches for MN.
